Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide

Poortvliet, R.K.E.; Peet, P.G. van; Craen, A.J.M. de; Mertens, B.J.A.; Mooijaart, S.P.; Wijsman, L.W.; ... ; Gussekloo, J. (2016)

Article / Letter to editor

• Aged
• cardiovascular disease
• pro-brain natriuretic peptide
• hydroxymethylglutaryl-CoA reductase inhibitors
• risk factors
• secondary prevention

• All authors: Poortvliet, R.K.E.; Peet, P.G. van; Craen, A.J.M. de; Mertens, B.J.A.; Mooijaart, S.P.; Wijsman, L.W.; Drewes, Y.M.; Ford, I.; Sattar, N.; Jukema, J.W.; Stott, D.J.; Ruijter, W. de; Gussekloo, J.
• Date: 2016-07-31
• Journal: European Journal of Preventive Cardiology
• Volume: 23
• Issue: 10
• Pages: 1104 - 1113
• DOI: doi:10.1177/2047487315617908